September 25, 2015
Tresiba and Ryzodeg get FDA’s approval
The U.S. Food and Drug Administration has approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
September 25, 2015
Johnson & Johnson completes divestiture of Splenda Brand to Heartland Food Products Group.
Johnson & Johnson Consumer Inc. has completed the divestiture of Splenda Brand to Heartland Food Products Group. Johnson & Johnson announced…
September 25, 2015
Novartis: New NIBR director named. Entresto closer to be available EU
Switzerland-based Novartis has today appointed Dr. James E. Bradner, physician-scientist from Dana-Farber Cancer Institute and Harvard Medical School, as President of the…
September 25, 2015
‘Novartis Access’, a portfolio of affordable medicines to treat chronic diseases in lower-income countries
Novartis has announced the launch of Novartis Access, a portfolio of 15 medicines to treat chronic diseases in low- and…
September 23, 2015
NIh: Clomiphene shows better results than letrozole for unexplained infertility
Treatment with clomiphene, a standard therapy for couples with unexplained infertility, results in more live births than treatment with a…
September 23, 2015
Phase 3 study of ABP 215 meets its endpoints
Amgen and Allergan plc. announced on Wednesday that a Phase 3 study of biosimilar candidate ABP 215 met its primary…
September 23, 2015
ViiV Healthcare announces results from STRIIVING HIV-1 study
ViiV Healthcare announced on Wednesday 24-week data from the Phase IIIb/IV Striiving study, an open-label study evaluating the efficacy, safety…
September 22, 2015
Taiho Oncology’s Lonsurf approved in USA
The U. S. Food and Drug Administration approved Taiho Oncology’s Lonsurf for the treatment of patients with metastatic colorectal cancer who…
September 22, 2015
FDA warns about Avycaz dosing errors
FDA is warning health care professionals about the risk for dosing errors with the intravenous antibacterial drug Avycaz (ceftazidime and…
September 22, 2015
Hillary Clinton reacts on AIDS drug jumping from $13 a tablet to $750
US presidential candidate from Democratic party, Hilary Clinton, has announced to make a plan about pricing medicine. After the news spread…